Conjugated Nanoparticles for Solid Tumor Theranostics

Bibliographic Details
Main Author: Chavda, Vivek P
Publication Date: 2023
Other Authors: Balar, Pankti C, Nalla, Lakshmi Vineela, Bezbaruah, Rajashri, Gogoi, Niva Rani, Gajula, Siva Nageswara Rao, Peng, Berney, Meena, Avtar S, Conde, João, Prasad, Rajendra
Format: Other
Language: eng
Source: Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
Download full: http://hdl.handle.net/10362/159718
Summary: © 2023 The Authors. Published by American Chemical Society.
id RCAP_db00452702a05a29c5dbb763d93302a5
oai_identifier_str oai:run.unl.pt:10362/159718
network_acronym_str RCAP
network_name_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository_id_str https://opendoar.ac.uk/repository/7160
spelling Conjugated Nanoparticles for Solid Tumor TheranosticsUnraveling the Interplay of Known and Unknown FactorsCancerCellsDrug deliveryMetal nanoparticlesNanoparticlesSDG 3 - Good Health and Well-being© 2023 The Authors. Published by American Chemical Society.Cancer diagnoses have been increasing worldwide, and solid tumors are among the leading contributors to patient mortality, creating an enormous burden on the global healthcare system. Cancer is responsible for around 10.3 million deaths worldwide. Solid tumors are one of the most prevalent cancers observed in recent times. On the other hand, early diagnosis is a significant challenge that could save a person's life. Treatment with existing methods has pitfalls that limit the successful elimination of the disorder. Though nanoparticle-based imaging and therapeutics have shown a significant impact in healthcare, current methodologies for solid tumor treatment are insufficient. There are multiple complications associated with the diagnosis and management of solid tumors as well. Recently, surface-conjugated nanoparticles such as lipid nanoparticles, metallic nanoparticles, and quantum dots have shown positive results in solid tumor diagnostics and therapeutics in preclinical models. Other nanotheranostic material platforms such as plasmonic theranostics, magnetotheranostics, hybrid nanotheranostics, and graphene theranostics have also been explored. These nanoparticle theranostics ensure the appropriate targeting of tumors along with selective delivery of cargos (both imaging and therapeutic probes) without affecting the surrounding healthy tissues. Though they have multiple applications, nanoparticles still possess numerous limitations that need to be addressed in order to be fully utilized in the clinic. In this review, we outline the importance of materials and design strategies used to engineer nanoparticles in the treatment and diagnosis of solid tumors and how effectively each method overcomes the drawbacks of the current techniques. We also highlight the gaps in each material platform and how design considerations can address their limitations in future research directions.Centre for Toxicogenomics and Human Health (ToxOmics)NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)RUNChavda, Vivek PBalar, Pankti CNalla, Lakshmi VineelaBezbaruah, RajashriGogoi, Niva RaniGajula, Siva Nageswara RaoPeng, BerneyMeena, Avtar SConde, JoãoPrasad, Rajendra2023-11-08T22:08:35Z2023-10-172023-10-17T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/other31application/pdfhttp://hdl.handle.net/10362/159718eng2470-1343PURE: 75498430https://doi.org/10.1021/acsomega.3c05069info:eu-repo/semantics/openAccessreponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiainstacron:RCAAP2025-05-26T01:40:56Zoai:run.unl.pt:10362/159718Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireinfo@rcaap.ptopendoar:https://opendoar.ac.uk/repository/71602025-05-28T17:46:18.151682Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiafalse
dc.title.none.fl_str_mv Conjugated Nanoparticles for Solid Tumor Theranostics
Unraveling the Interplay of Known and Unknown Factors
title Conjugated Nanoparticles for Solid Tumor Theranostics
spellingShingle Conjugated Nanoparticles for Solid Tumor Theranostics
Chavda, Vivek P
Cancer
Cells
Drug delivery
Metal nanoparticles
Nanoparticles
SDG 3 - Good Health and Well-being
title_short Conjugated Nanoparticles for Solid Tumor Theranostics
title_full Conjugated Nanoparticles for Solid Tumor Theranostics
title_fullStr Conjugated Nanoparticles for Solid Tumor Theranostics
title_full_unstemmed Conjugated Nanoparticles for Solid Tumor Theranostics
title_sort Conjugated Nanoparticles for Solid Tumor Theranostics
author Chavda, Vivek P
author_facet Chavda, Vivek P
Balar, Pankti C
Nalla, Lakshmi Vineela
Bezbaruah, Rajashri
Gogoi, Niva Rani
Gajula, Siva Nageswara Rao
Peng, Berney
Meena, Avtar S
Conde, João
Prasad, Rajendra
author_role author
author2 Balar, Pankti C
Nalla, Lakshmi Vineela
Bezbaruah, Rajashri
Gogoi, Niva Rani
Gajula, Siva Nageswara Rao
Peng, Berney
Meena, Avtar S
Conde, João
Prasad, Rajendra
author2_role author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Centre for Toxicogenomics and Human Health (ToxOmics)
NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)
RUN
dc.contributor.author.fl_str_mv Chavda, Vivek P
Balar, Pankti C
Nalla, Lakshmi Vineela
Bezbaruah, Rajashri
Gogoi, Niva Rani
Gajula, Siva Nageswara Rao
Peng, Berney
Meena, Avtar S
Conde, João
Prasad, Rajendra
dc.subject.por.fl_str_mv Cancer
Cells
Drug delivery
Metal nanoparticles
Nanoparticles
SDG 3 - Good Health and Well-being
topic Cancer
Cells
Drug delivery
Metal nanoparticles
Nanoparticles
SDG 3 - Good Health and Well-being
description © 2023 The Authors. Published by American Chemical Society.
publishDate 2023
dc.date.none.fl_str_mv 2023-11-08T22:08:35Z
2023-10-17
2023-10-17T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/other
format other
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10362/159718
url http://hdl.handle.net/10362/159718
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 2470-1343
PURE: 75498430
https://doi.org/10.1021/acsomega.3c05069
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 31
application/pdf
dc.source.none.fl_str_mv reponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron:RCAAP
instname_str FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron_str RCAAP
institution RCAAP
reponame_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
collection Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository.name.fl_str_mv Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
repository.mail.fl_str_mv info@rcaap.pt
_version_ 1833596948165165056